Inc. (Nasdaq: MNMD), (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product ...

(Nasdaq: CLYM) today announced that the company will be added to the NASDAQ Biotech Index (Nasdaq: NBI) as part of the annual ...

Shares of Altimmune, Inc. climbed early on Thursday, recovering from a nearly 6% drop in the previous session, drawing ...

CorMedix (CRMD) announced it will be added to the Nasdaq Biotechnology Index (NBI). CorMedix’s addition to the NBI will become effective prior to the market open on Monday, December 23, 2024.

CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced it will be added ...

It’s clear that the biotech sector’s potential is far from being fully realized, especially when companies like Mesoblast are breaking new ground. Mesoblast is not just another biotech company; it is ...

The American depositary receipts of Mesoblast were trading higher after hours Wednesday following news the company will be added to the Nasdaq Biotechnology Index, effective Dec. 23. After the bell, ...

Dec. 19, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will be added to the Nasdaq Biotechnology Index (Nasdaq: NBI) ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only ... Source: FactSet Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only ... Source: FactSet Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to ...

AnaptysBio (NASDAQ:ANAB – Get Free Report) had its price target decreased by research analysts at Truist Financial from $30.00 to $20.00 in a report released on Wednesday,Benzinga reports. The firm ...

Oruka Therapeutics, Inc. ("Oruka") (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a new standard for the treatment ...